Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression
- 1 June 2005
- journal article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 33 (3) , 279-284
Abstract
Background: P-glycoprotein (P-gp) has been identified as a possible mediator of chemoresistance in retinoblastoma. the aim of this study was to determine the expression of P-gp in retinoblastoma treated with chemotherapy prior to enucleation.Methods: Seventeen enucleated specimens of retinoblastoma from 16 patients were studied. Nine had been treated with chemotherapy alone, and eight had been treated with chemotherapy and other forms of local treatment. Tumour differentiation as well as choroidal and optic nerve invasion were assessed. P-gp immunohistochemical staining was performed and evaluated as negative, low or high.Results: Histopathological assessment of the cases showed that 14 of 17 eyes (82.3%) had viable retinoblastoma cells. Nine retinoblastomas were considered regressed with a well-differentiated component, five regressed retinoblastomas had viable cells with poor differentiation and three retinoblastomas had regressed leaving no viable cells. Sixteen of 17 retinoblastomas were P-gp positive. in the one case with optic nerve invasion and the three cases with massive choroidal invasion, P-gp expression was found in invading retinoblastoma cells.Conclusion: Almost all retinoblastomas expressed P-gp. High levels of P-gp expression might play a role in chemotherapy resistance of retinoblastoma or, conversely, chemotherapy might induce P-gp expression. These results might have an impact on management of bilateral retinoblastoma.Universidade Federal de São Paulo, Dept Ophthalmol, São Paulo, BrazilMcGill Univ, Henry C Witelson Ocular Pathol Lab, Dept Ophthalmol, Montreal, PQ, CanadaUniversidade Federal de São Paulo, Dept Ophthalmol, São Paulo, BrazilWeb of SciencKeywords
This publication has 15 references indexed in Scilit:
- Globe conserving treatment of the only eye in bilateral retinoblastomaBritish Journal of Ophthalmology, 2003
- Emerging strategies for the treatment of retinoblastomaCurrent Opinion in Ophthalmology, 2003
- DiscussionOphthalmology, 2003
- Histopathologic Findings in Eyes With Retinoblastoma Treated Only With ChemoreductionArchives of Ophthalmology (1950), 2003
- Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-GlycoproteinCancer Control, 2003
- Chemothermotherapy in the management of retinoblastoma1 1None of the authors have any financial interests in the drugs or devices described in this article.Ophthalmology, 2002
- Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without RadiotherapyArchives of Ophthalmology (1950), 1996
- Multidrug resistance in ocular melanoma.British Journal of Ophthalmology, 1996
- P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for NeuroblastomaNew England Journal of Medicine, 1991
- Multidrug-resistant Phenotype in Retinoblastoma Correlates with P-glycoprotein ExpressionOphthalmology, 1991